Navigation Links
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
Date:5/17/2013

SAN DIEGO, May 17, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the UBS Global Healthcare Conference in New York. The presentation is scheduled for Wednesday, May 22nd at 11 a.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase 3 clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com.Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2020)... ... September 03, 2020 , ... Q&J Face Masks announced today ... aerosol and engineering lab, conducted tests on Q&J’s personal face mask that indicated ... many other masks. Q&J face masks have both mechanical filtering and electrostatic filtering ...
(Date:9/2/2020)... ... September 02, 2020 , ... Rigaku ... a roundtable discussion among industry professionals about successes and challenges of making changes ... American Pharmaceutical Review and will take place on October 15, 2020 at ...
(Date:9/1/2020)... CLARA, Calif. (PRWEB) , ... September 01, 2020 ... ... and analytical laboratory technologies, will host the Agilent Science and Technology Virtual ... During this two-day symposium, Agilent will open a suite of Live webinars and ...
Breaking Medicine Technology:
(Date:9/2/2020)... ... September 02, 2020 , ... RAM ... payers administering Medicare Advantage and Special Needs plans, is proud to support the ... Insurance Plans (AHIP). RAM is supporting the event as a sponsor and exhibitor ...
(Date:9/1/2020)... ... September 01, 2020 , ... KitoTech Medical, a Seattle-based ... financing, which will be used to accelerate the commercialization of its microMend® family ... company will continue to expand its customer base of healthcare systems as well ...
(Date:9/1/2020)... ... September 01, 2020 , ... As fall and winter swiftly ... Cohn Health Institute has taken this time to expand and grow into a ... Anniversary, the Cohn Health Institute will be relaunching its brand new website, expanding its ...
(Date:8/31/2020)... ... August 31, 2020 , ... Cardiothoracic surgeons at Allegheny General ... Carnegie Mellon University (CMU) to develop a new heart monitoring device designed to ... surgery. , The AGH/CMU team was recently awarded a “Trailblazer” grant from the ...
(Date:8/31/2020)... ... , ... Just found out your dear friend has cancer? , It’s hard to hear your ... shares their diagnosis. Once the shock wears off, the questions and fears can be overwhelming. ... best ways to help? Words are failing me. I’m scared. I want to DO something. ...
Breaking Medicine News(10 mins):